Package 0115-5445-13

{"route": ["ORAL"], "spl_id": "cb660c34-cfd0-4598-a767-db8a82e087e0", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993536"], "spl_set_id": ["e962fb9a-d9fb-49c5-a8b4-0b355b8f829b"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-5445-13)", "package_ndc": "0115-5445-13", "marketing_start_date": "20041203"}], "brand_name": "Bupropion Hydrochloride", "product_id": "0115-5445_cb660c34-cfd0-4598-a767-db8a82e087e0", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0115-5445", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "200 mg/1"}], "application_number": "ANDA076711", "marketing_category": "ANDA", "marketing_start_date": "20041203", "listing_expiration_date": "20261231"}